More information
Description
Established in Craiova in 2020, Silosi Medical Tech is at the forefront of healthcare and technology convergence. With support from the EEA and Norway Grants, the company aims to enhance the DEA Medicine platform, a hub for medical professionals and patients. Launched in 2022 with over 60 medical professionals and 250 monthly active users, DEA Medicine offers features like patient profiles, doctor scheduling, user management, and a specialized search engine. Silosi Medical Tech is currently pioneering an AI-driven postoperative monitoring tool, promising to revolutionize surgical recovery.
Development of a telemedicine solution for the surgical care, by introducing an AI postoperative monitoring tool. Further it aims to increase Silosi Medical Tech''s competitiveness in the market. This aims to result in 2 new jobs and significantly increased turnover.
Achieving these goals require a series of key activities, including:
- Project Management
- Project Promotion
- Personlized monitoring package
- Investment activity
This project also contains a strong bilateral component. Through a partnership with Norwegian company OSINT (Open Source Intelligence) Analytics, a very helpful exchange of expertise will take place. Their skills will help to better understand specific needs in the European Union postoperative care plans and adapt the solution to address those needs and grow the user base in the donor state. In the medium, to long term, we are expecting to start working on new innovative solutions developed with our know-how and expertise in the medical sector and OSINTs technology background and data analysis capabilities. This contributes to the main indicator of the program, which is generating an increased level of trust between cooperating entities in the Beneficiary state and Donor State, consolidating our bilateral relationships and opening the doors for other partnerships and success stories in the years to come.